-
Alan Greenspan: longtime Fed chief with a divided legacy
-
Leinster boss Cullen to step down at end of next season
-
'Has-been' Belgium stars scorched after Iran World Cup draw
-
Oil falls on US-Iran progress; pound holds up as Starmer resigns
-
Starmer resigns as UK PM, Burnham favourite to take over
-
France, Germany reach deal on arms maker KNDS, paving way for IPO
-
Latest developments on Europe's heatwave
-
France set for hottest day yet of heatwave
-
Keir Starmer: downfall of UK's unpopular PM
-
Gaza's surfers seek solace in the sea
-
MEXC Lists Arcium (ARX) with 70,000 USDT in Airdrop+ Rewards
-
EasyJet rejects £5 bn takeover offer from US equity firm
-
Europe scorched by latest heatwave
-
Mediators hail 'progress' in US-Iran talks after lengthy opening session
-
UK's Starmer resigns as prime minister
-
Coffee break: Starbucks Korea stores pause for training after 'Tank Day' fiasco
-
Rightist leaders congratulate Colombian president-elect
-
Rare Philippine school shooting kills three teens, wounds seven
-
Kenya labour minister accused over Russian forced recruitment
-
Crude prices drop after 'positive' US-Iran talks
-
Some France schools closed for day of searing heat
-
Tuchel's England face defensive questions despite flying start at World Cup
-
Frankfurt to All Blacks: New Zealand pick first German-born player
-
Not just a hideout: Sahel forests provide base for jihadists
-
Ageless Messi has World Cup scoring record in his sights
-
Africa faces child surgery crisis as key anaesthesia runs out
-
Trump-backed populist wins razor-tight Colombia vote, sparking protests
-
J-Bay: S.Africa's surf mecca missing out on the global tour
-
'Progress', say mediators, after Iran-US talks towards ending war
-
Key points from the first round of Iran-US talks
-
European countries close schools, cancel trains as heatwave set to intensify
-
Crude prices drop, most stocks rise on 'positive' US-Iran talks
-
'Progress', say mediators, after Iran-US talks on ending war
-
Slimy beans: Japanese natto disgusts and delights the world
-
Clark wins despite hecklers but hopes not to be 'heel of the PGA'
-
Cape Verde targeting World Cup knockout rounds after Uruguay draw: coach
-
Father's Day near-miss at US Open brings Burns to tears
-
New coach Rennie names Savea as All Blacks captain
-
Scheffler praises Clark's resolve in gutsy US Open triumph
-
Yamal kickstarts Spain World Cup bid as Cape Verde stun Uruguay
-
Cape Verde fight back for second World Cup draw against Uruguay
-
Mexican fans rally behind Iran as 'our second team' at World Cup
-
Iran-US talks to continue through the night
-
Trump-backed candidate wins razor-tight Colombia presidential election
-
Clark edges Burns by one stroke for second US Open title
-
Iran coach hails 'great achievement' after second World Cup draw
-
Curacao firmly on the map after World Cup heroics
-
Pro-Trump presidential hopeful takes early lead as Colombia counts votes
-
Trump say repairs to begin 'immediately' for Washington pool renovation
-
Yamal off the mark at World Cup in Spain rout as Iran hold Belgium
US Justice Dept takes abortion pill fight to Supreme Court
The US Justice Department said Thursday that it will go to the Supreme Court to appeal restrictions imposed on a widely-used abortion pill in the latest round of an intensifying battle over reproductive rights.
The move by the administration of President Joe Biden came just hours after an appeals court blocked moves to ban mifepristone, but limited access to the drug used for more than half of the abortions in the United States.
"We will be seeking emergency relief from the Supreme Court... to protect Americans' access to safe and effective reproductive care," US Attorney General Merrick Garland said.
Speaking to reporters during Biden's visit to Dublin, Ireland, White House Press Secretary Karine Jean-Pierre said "we believe that the law is on our side, and we will prevail."
Late Wednesday, the US Fifth Circuit Court of Appeals said mifepristone should remain available for now, but limited access to the first seven weeks of pregnancy, down from 10.
The appeals court also said in-person visits would be necessary to obtain the pill -- a requirement lifted in recent years -- and blocked the medication from being sent by mail.
The 2-1 ruling by the conservative-majority federal appeals court in New Orleans, Louisiana, came after a US District Court judge in Texas overturned the Food and Drug Administration's two-decades old approval of the drug last Friday.
The appeals court ruling was denounced by Planned Parenthood, the ACLU, the Center for Reproductive Rights and other groups seeking to maintain access to abortion.
"We are furious that yet another court would choose to jeopardize the health and futures of the millions of people who rely on mifepristone for abortion care," said Planned Parenthood president Alexis McGill Johnson.
Jennifer Dalven, director of the ACLU Reproductive Freedom Project, said "unless the Supreme Court steps in, this decision will prevent many people from getting abortion care and force them to remain pregnant against their will."
- 'Win' -
The anti-abortion group Susan B. Anthony described the latest ruling by two judges appointed by former Republican president Donald Trump as a "win."
"The court recognized that the abortion pill is dangerous and rolled back Biden's reckless mail-order abortion scheme," said Susan B. Anthony state policy director Katie Daniel. "We look forward to the Supreme Court hearing this case."
The latest standoff over women's reproductive freedom in America comes almost a year after the conservative-dominated Supreme Court overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.
Mifepristone is one component of a two-drug regimen that can be used in the United States through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.
Last week's ruling by Judge Matthew Kacsmaryk, also a Trump appointee, imposing a nationwide ban on mifepristone came in response to a suit by a coalition of anti-abortion groups.
The judge, in his decision, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."
Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.
Shortly after the initial Texas decision, a judge in Washington state ruled in a separate case that access to mifepristone must be preserved.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access the procedure -- or ban it outright.
J.Bergmann--BTB